In the News Pyrexar HT Hyperthermia


ASTRO2015Salt Lake City, UT– Pyrexar Medical, leaders in thermal therapy systems, will be exhibiting at the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting held in San Antonio’s Henry B. Gonzalez Convention Center on October 18-20,2015.

Pyrexar will showcase their line of superficial, interstitial and deep regional hyperthermia systems for the treatment of cancer. Clinical studies confirm that hyperthermia added to radiotherapy boosts effective dose and increases response rate without any cumulative damage to healthy tissues. Thermal Therapy is one of the most important new cancer therapies on the market and it is under-represented in the U.S.  Pyrexar will be the only manufacturer of this technology exhibiting at the show.

It has been a very big year for the newly formed Pyrexar. Since purchasing the assets from the 30-year-old device manufacturer BSD Medical, the company has experienced phenomenal growth. This growth coincides with important clinical findings supporting the use of thermal therapy, aka hyperthermia, to treat cancer. The most recent peer review (published in Cancer Treatment Reviews) of 38 clinical studies, including cancers of the bladder, breast, cervical, esophageal, head & neck, pediatric tumors, rectal and soft tissue sarcoma, concludes that adding hyperthermia to traditional cancer treatment improves outcomes by an average of 1.8.

“There is no better time to talk about the benefits of thermal therapy than now”, says Mark Falkowski, CEO at Pyrexar Medical.  “We are seeing an improvement in outcomes by adding a pain-free, harm-free treatment protocol to the standard of care.  Why wouldn’t you give that to a loved one if it could mean more time.” Pyrexar will be launching its #OneMoreYear campaign at the show, challenging everyone to think about what they would do if given one more year.

You can find Pyrexar at booth 1753 at the ASTRO show October 18, 19 & 20 and later this year at RSNA Nov. 29th - Dec 4th in Chicago. To learn more about Pyrexar products and be part of the #OneMoreYear campaign, visit

Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective thermal therapy/hyperthermia treatment systems with established distribution and support networks around the world. PYREXAR HyperThermia (PYREXAR HT) treatments, proven in multiple clinical trials over the last 30 years, increase the effective dose of ionizing radiation in solid tumors up to 3X without increasing toxicity to healthy tissues.

News Archive

  • PYREXAR Medical Acquires Hyperthermia Assets of BSD Medical +

    Promising Cancer Treatment Technology Now Under New Leadership Salt Lake Read More
  • Pyrexar Medical closes deal with HanBeam Technology +

    Hyperthermia products find distribution in South Korea Salt Lake City, Read More
  • Pyrexar Chief Scientist Goes to China +

    PYREXAR HT Hyperthermia products find distribution with Orientech SALT LAKE Read More
  • Pyrexar Medical expands Hyperthermia to Central Asia +

    PYREXAR HT Hyperthermia products find distribution with ORB Corporation SALT Read More
  • Pyrexar brings the Fight Against Cancer to South Korea +

    Pyrexar receives final authorization to sell Thermal Therapy devices in Read More
  • 1
  • 2
  • 3

Contact Info

We are pleased to hear from you. If we can help you with Pyrexar HT products, Clinical Studies or the Advancement of Hyperthermia. We would love to hear what you have to say.




1825 West Research Way, Ste E
Salt Lake City, UT 84119, USA

Spread the word about Hyperthermia.